+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gene Synthesis Market by Product, Method, Gene Type, Application, End-use - Global Forecast 2025-2030- Product Image
Gene Synthesis Market by Product, Method, Gene Type, Application, End-use - Global Forecast 2025-2030- Product Image
Sale

Gene Synthesis Market by Product, Method, Gene Type, Application, End-use - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 193 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5715509
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Gene Synthesis Market grew from USD 4.24 billion in 2023 to USD 4.68 billion in 2024. It is expected to continue growing at a CAGR of 10.82%, reaching USD 8.70 billion by 2030.

Gene synthesis, the artificial production of DNA sequences, allows for precise modifications to genetic material, making it a cornerstone in biological research and biotechnology applications. This field holds significant importance in areas such as synthetic biology, personalized medicine, and pharmaceuticals, enabling advancements like the production of recombinant proteins, development of gene therapies, and creation of genetically modified organisms (GMOs). The gene synthesis market is driven by the escalating demand for custom genes and the increasing focus on research activities in genomics. Factors like the rising incidences of genetic disorders and the expanding application of gene synthesis in vaccine development further propel market growth. However, challenges such as high costs, complex regulatory environments, and ethical concerns regarding genetic modification can act as barriers. Regional inconsistencies in governmental regulations also add to these challenges, potentially limiting market expansion.

Opportunities lie in the integration of AI and machine learning to streamline design processes, enhancing both accuracy and efficiency. Companies can leverage these technologies to reduce synthesis time and costs, tapping into high-growth sectors like precision medicine and agriculture. Additionally, the rise in CRISPR-based technologies creates new avenues for innovation, particularly in therapeutic development. To capitalize on these opportunities, businesses should focus on collaborative partnerships with academic and research institutions to foster innovation and accelerate product development. Enhancing the scalability of gene synthesis techniques and automating workflow processes can provide a competitive edge.

Overall, while the gene synthesis market presents numerous growth opportunities, addressing existing limitations through technological advancements and regulatory harmonization is crucial. Continuous investment in R&D and forming strategic alliances can ultimately lead to substantial market growth and enable the introduction of next-generation therapeutic and agricultural products.

Understanding Market Dynamics in the Gene Synthesis Market

The Gene Synthesis Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Prevalence of chronic conditions among the global population
    • Increasing genomics research activities and rising focus on personalized medicines
    • Growing investments by the private and public sectors in pharmaceutical research
  • Market Restraints
    • Strict regulations governing gene synthesis and high cost associated with the process
  • Market Opportunities
    • Emerging new technologies in gene synthesis
    • Utilization of gene synthesis in energy and agriculture industries
  • Market Challenges
    • Limitations in size and complexity of synthetic genes

Exploring Porter’s Five Forces for the Gene Synthesis Market

Porter’s Five Forces framework further strengthens the insights of the Gene Synthesis Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Gene Synthesis Market

External macro-environmental factors deeply influence the performance of the Gene Synthesis Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Gene Synthesis Market

The Gene Synthesis Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Gene Synthesis Market

The Gene Synthesis Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Key Company Profiles

The report delves into recent significant developments in the Gene Synthesis Market, highlighting leading vendors and their innovative profiles. These include Biomatik Corporation, Biotech Desk Pvt. Ltd., Twist Bioscience Corporation, ProteoGenix SAS, Creative Biogene, Biotage AB, General Biosystems, Inc., Ansa Biotechnologies, Inc., ProMab Biotechnologies, Inc., Barcode Biosciences Private Limited, DNA TwoPointO Inc., Elabscience Biotechnology Inc., Eurofins Scientific SE, Telesis Bio Inc., Macrogen, Inc., Elegen Corp., Gene Universal, Inc., Charles River Laboratories International, Inc., Thermo Fisher Scientific Inc., Synbio Technologies LLC, Danaher Corporation, Constructive Bio Ltd, GenCefe Biotech Limited, NZYTech, Lda., Evonetix Ltd., OriGene Technologies, Inc., BGI Genomics by BGI Group, Boster Biological Technology, Bioneer Corporation, Brooks Automation Inc., QIAGEN N.V., Agilent Technologies, Inc., Merck KGaA, AstraZeneca PLC, Ginkgo Bioworks Holdings, Inc., GenScript Biotech Corporation, Camena Bioscience, Azenta, Inc., BioCat GmbH by AddLife AB, and Applied Biological Materials Inc..

Market Segmentation & Coverage

This research report categorizes the Gene Synthesis Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product
    • Hardware
    • Services
      • Antibody DNA Synthesis
      • Viral DNA Synthesis
    • Software
  • Method
    • Chip-Based Synthesis
    • PCR-Based Enzyme Synthesis
    • Solid-Phase Synthesis
  • Gene Type
    • Complex Gene
    • Express Gene
    • Standard Gene
  • Application
    • Disease Diagnosis
    • Gene & Cell Therapy Development
    • Vaccine Development
  • End-use
    • Academic & Government Research Institutes
    • Biotechnology & Pharmaceutical Companies
    • Contract Research Organizations
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Prevalence of chronic conditions among the global population
5.1.1.2. Increasing genomics research activities and rising focus on personalized medicines
5.1.1.3. Growing investments by the private and public sectors in pharmaceutical research
5.1.2. Restraints
5.1.2.1. Strict regulations governing gene synthesis and high cost associated with the process
5.1.3. Opportunities
5.1.3.1. Emerging new technologies in gene synthesis
5.1.3.2. Utilization of gene synthesis in energy and agriculture industries
5.1.4. Challenges
5.1.4.1. Limitations in size and complexity of synthetic genes
5.2. Market Segmentation Analysis
5.2.1. Product: Expanding usage of software that helps design synthetic genes accurately
5.2.2. Method: Rising utilization of chip-based synthesis for large-scale projects
5.2.3. Gene Type: Growing potential for express gene synthesis that provides quick access to shorter genes for time-sensitive projects
5.2.4. End-use: Increasing focus on innovative drug discovery and therapeutic development across biotechnology and pharmaceutical companies
5.2.5. Gene Type: Growing potential of express genes that are optimized for high levels of expression in specific host organisms
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Gene Synthesis Market, by Product
6.1. Introduction
6.2. Hardware
6.3. Services
6.3.1. Antibody DNA Synthesis
6.3.2. Viral DNA Synthesis
6.4. Software
7. Gene Synthesis Market, by Method
7.1. Introduction
7.2. Chip-Based Synthesis
7.3. PCR-Based Enzyme Synthesis
7.4. Solid-Phase Synthesis
8. Gene Synthesis Market, by Gene Type
8.1. Introduction
8.2. Complex Gene
8.3. Express Gene
8.4. Standard Gene
9. Gene Synthesis Market, by Application
9.1. Introduction
9.2. Disease Diagnosis
9.3. Gene & Cell Therapy Development
9.4. Vaccine Development
10. Gene Synthesis Market, by End-use
10.1. Introduction
10.2. Academic & Government Research Institutes
10.3. Biotechnology & Pharmaceutical Companies
10.4. Contract Research Organizations
11. Americas Gene Synthesis Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Gene Synthesis Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Gene Synthesis Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
14.3.1. Evonetix and Analog Devices Inc To Progress Revolutionary Gene Synthesis Platform
14.3.2. Gyros Protein Technologies and Biotage Partner to Advance Peptide Purification Efficiency With New Automated Solution
14.3.3. Synplogen and Ginkgo Bioworks Announce Plans to Accelerate Global DNA Manufacturing and Gene Therapy Platform Services in Japan
14.3.4. Twist Bioscience Launches Express Genes Rapid Gene Synthesis Service
14.3.5. Biotech Firm Closes GBP 5.6 million Seed Financing
14.3.6. Bruker to Buy PhenomeX For USD 108 Million
14.3.7. Series Funding to Support Expansion of DNA Synthesis Technology
14.3.8. NunaBio Raises GBP 1.9M In Seed Funding To Expand Infrastructure And Accelerate R&D
14.3.9. Elegen Launches ENFINIA DNA, Rapid Long DNA Synthesis to Power the Bioeconomy
14.3.10. Ansa Biotechnologies Announces Successful de novo Synthesis of Oligonucleotide at 1005 Bases
14.3.11. GenScript Expands Footprint in Singapore to Provide Premium Gene Synthesis Service
14.3.12. Evonetix Closes USD 24 million Financing
14.3.13. Gene Synthesis (End-to-End) Now In India At Barcode Biosciences
14.3.14. Eurofins Genomics Blue Heron launches IVT mRNA Synthesis Service: The Future of Gene Expression
List of Figures
FIGURE 1. GENE SYNTHESIS MARKET RESEARCH PROCESS
FIGURE 2. GENE SYNTHESIS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL GENE SYNTHESIS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL GENE SYNTHESIS MARKET SIZE, BY METHOD, 2023 VS 2030 (%)
FIGURE 9. GLOBAL GENE SYNTHESIS MARKET SIZE, BY METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2023 VS 2030 (%)
FIGURE 11. GLOBAL GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 13. GLOBAL GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL GENE SYNTHESIS MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
FIGURE 15. GLOBAL GENE SYNTHESIS MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. AMERICAS GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. AMERICAS GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 19. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. GENE SYNTHESIS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 25. GENE SYNTHESIS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. GENE SYNTHESIS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL GENE SYNTHESIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GENE SYNTHESIS MARKET DYNAMICS
TABLE 7. GLOBAL GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL GENE SYNTHESIS MARKET SIZE, BY HARDWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL GENE SYNTHESIS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL GENE SYNTHESIS MARKET SIZE, BY ANTIBODY DNA SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL GENE SYNTHESIS MARKET SIZE, BY VIRAL DNA SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL GENE SYNTHESIS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL GENE SYNTHESIS MARKET SIZE, BY CHIP-BASED SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL GENE SYNTHESIS MARKET SIZE, BY PCR-BASED ENZYME SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL GENE SYNTHESIS MARKET SIZE, BY SOLID-PHASE SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL GENE SYNTHESIS MARKET SIZE, BY COMPLEX GENE, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL GENE SYNTHESIS MARKET SIZE, BY EXPRESS GENE, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL GENE SYNTHESIS MARKET SIZE, BY STANDARD GENE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL GENE SYNTHESIS MARKET SIZE, BY DISEASE DIAGNOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL GENE SYNTHESIS MARKET SIZE, BY GENE & CELL THERAPY DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL GENE SYNTHESIS MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL GENE SYNTHESIS MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL GENE SYNTHESIS MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL GENE SYNTHESIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 40. ARGENTINA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 41. ARGENTINA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 42. ARGENTINA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 44. BRAZIL GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 45. BRAZIL GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 46. BRAZIL GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 47. BRAZIL GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. BRAZIL GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 49. CANADA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 50. CANADA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 51. CANADA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 52. CANADA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 53. CANADA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 54. CANADA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 55. MEXICO GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 56. MEXICO GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 57. MEXICO GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 58. MEXICO GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 59. MEXICO GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. MEXICO GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 68. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 69. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 70. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 72. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 74. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 75. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 76. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 77. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 78. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 79. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 81. CHINA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 82. CHINA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 83. CHINA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 84. CHINA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 85. CHINA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. CHINA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 87. INDIA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 88. INDIA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 89. INDIA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 90. INDIA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 91. INDIA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. INDIA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 93. INDONESIA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 94. INDONESIA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 95. INDONESIA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 96. INDONESIA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 97. INDONESIA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. INDONESIA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 99. JAPAN GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 100. JAPAN GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 101. JAPAN GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 102. JAPAN GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 103. JAPAN GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. JAPAN GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 105. MALAYSIA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 106. MALAYSIA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 107. MALAYSIA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 108. MALAYSIA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 109. MALAYSIA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. MALAYSIA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 111. PHILIPPINES GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 112. PHILIPPINES GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 113. PHILIPPINES GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 114. PHILIPPINES GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 115. PHILIPPINES GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. PHILIPPINES GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 117. SINGAPORE GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 118. SINGAPORE GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 119. SINGAPORE GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 120. SINGAPORE GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 121. SINGAPORE GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. SINGAPORE GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 123. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 124. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 125. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 126. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 127. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 129. TAIWAN GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 130. TAIWAN GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 131. TAIWAN GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 132. TAIWAN GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 133. TAIWAN GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. TAIWAN GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 135. THAILAND GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 136. THAILAND GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 137. THAILAND GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 138. THAILAND GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 139. THAILAND GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. THAILAND GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 141. VIETNAM GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 142. VIETNAM GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 143. VIETNAM GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 144. VIETNAM GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 145. VIETNAM GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. VIETNAM GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 154. DENMARK GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 155. DENMARK GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 156. DENMARK GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 157. DENMARK GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 158. DENMARK GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 159. DENMARK GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 160. EGYPT GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 161. EGYPT GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 162. EGYPT GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 163. EGYPT GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 164. EGYPT GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 165. EGYPT GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 166. FINLAND GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 167. FINLAND GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 168. FINLAND GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 169. FINLAND GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 170. FINLAND GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 171. FINLAND GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 172. FRANCE GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 173. FRANCE GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 174. FRANCE GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 175. FRANCE GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 176. FRANCE GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 177. FRANCE GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 178. GERMANY GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 179. GERMANY GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 180. GERMANY GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 181. GERMANY GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 182. GERMANY GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 183. GERMANY GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 184. ISRAEL GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 185. ISRAEL GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 186. ISRAEL GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 187. ISRAEL GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 188. ISRAEL GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 189. ISRAEL GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 190. ITALY GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 191. ITALY GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 192. ITALY GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 193. ITALY GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 194. ITALY GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 195. ITALY GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 196. NETHERLANDS GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 197. NETHERLANDS GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 198. NETHERLANDS GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 199. NETHERLANDS GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 200. NETHERLANDS GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 201. NETHERLANDS GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 202. NIGERIA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 203. NIGERIA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 204. NIGERIA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 205. NIGERIA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 206. NIGERIA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 207. NIGERIA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 208. NORWAY GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 209. NORWAY GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 210. NORWAY GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 211. NORWAY GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 212. NORWAY GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 213. NORWAY GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 214. POLAND GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 215. POLAND GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 216. POLAND GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 217. POLAND GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 218. POLAND GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 219. POLAND GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 220. QATAR GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 221. QATAR GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 222. QATAR GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 223. QATAR GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 224. QATAR GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 225. QATAR GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 226. RUSSIA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 227. RUSSIA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 228. RUSSIA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 229. RUSSIA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 230. RUSSIA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 231. RUSSIA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 232. SAUDI ARABIA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 234. SAUDI ARABIA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 236. SAUDI ARABIA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 238. SOUTH AFRICA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 240. SOUTH AFRICA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 242. SOUTH AFRICA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 244. SPAIN GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 245. SPAIN GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 246. SPAIN GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 247. SPAIN GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 248. SPAIN GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 249. SPAIN GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 250. SWEDEN GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 251. SWEDEN GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 252. SWEDEN GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 253. SWEDEN GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 254. SWEDEN GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 255. SWEDEN GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 256. SWITZERLAND GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 257. SWITZERLAND GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 258. SWITZERLAND GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 261. SWITZERLAND GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 262. TURKEY GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 263. TURKEY GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 264. TURKEY GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 265. TURKEY GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 266. TURKEY GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 267. TURKEY GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 268. UNITED ARAB EMIRATES GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 274. UNITED KINGDOM GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 276. UNITED KINGDOM GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 278. UNITED KINGDOM GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 280. GENE SYNTHESIS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 281. GENE SYNTHESIS MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Gene Synthesis market, which are profiled in this report, include:
  • Biomatik Corporation
  • Biotech Desk Pvt. Ltd.
  • Twist Bioscience Corporation
  • ProteoGenix SAS
  • Creative Biogene
  • Biotage AB
  • General Biosystems, Inc.
  • Ansa Biotechnologies, Inc.
  • ProMab Biotechnologies, Inc.
  • Barcode Biosciences Private Limited
  • DNA TwoPointO Inc.
  • Elabscience Biotechnology Inc.
  • Eurofins Scientific SE
  • Telesis Bio Inc.
  • Macrogen, Inc.
  • Elegen Corp.
  • Gene Universal, Inc.
  • Charles River Laboratories International, Inc.
  • Thermo Fisher Scientific Inc.
  • Synbio Technologies LLC
  • Danaher Corporation
  • Constructive Bio Ltd
  • GenCefe Biotech Limited
  • NZYTech, Lda.
  • Evonetix Ltd.
  • OriGene Technologies, Inc.
  • BGI Genomics by BGI Group
  • Boster Biological Technology
  • Bioneer Corporation
  • Brooks Automation Inc.
  • QIAGEN N.V.
  • Agilent Technologies, Inc.
  • Merck KGaA
  • AstraZeneca PLC
  • Ginkgo Bioworks Holdings, Inc.
  • GenScript Biotech Corporation
  • Camena Bioscience
  • Azenta, Inc.
  • BioCat GmbH by AddLife AB
  • Applied Biological Materials Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages193
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 4.68 Billion
Forecasted Market Value ( USD ) by 2030 $ 8.7 Billion
Compound Annual Growth Rate10.8%
Regions CoveredGlobal
No. of Companies Mentioned41

Related Topics

Related Reports

DNA Synthesis Market Size, Share & Trends Analysis Report by Service Type (Gene Synthesis, Oligonucleotide Synthesis), Length, Application (Research Development, Diagnostics), End-use, Region, and Segment Forecasts, 2024-2030 - Product Image

DNA Synthesis Market Size, Share & Trends Analysis Report by Service Type (Gene Synthesis, Oligonucleotide Synthesis), Length, Application (Research Development, Diagnostics), End-use, Region, and Segment Forecasts, 2024-2030

  • Report
  • 120 Pages
  • Global
From
DNA And Gene Cloning Services Market Size, Share & Trends Analysis Report By Service (Gene Synthesis, Custom Cloning), By Application (DNA Sequencing, Mutagenesis), By End Use, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

DNA And Gene Cloning Services Market Size, Share & Trends Analysis Report By Service (Gene Synthesis, Custom Cloning), By Application (DNA Sequencing, Mutagenesis), By End Use, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 120 Pages
  • Global
From
Gene Synthesis Market Global Market Report 2024 - Product Image

Gene Synthesis Market Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Gene Synthesis Market Report and Forecast 2024-2032 - Product Image

Gene Synthesis Market Report and Forecast 2024-2032

  • Report
  • 140 Pages
  • Global
From
Gene Synthesis: Technologies and Global Markets 2023-2028 - Product Image

Gene Synthesis: Technologies and Global Markets 2023-2028

  • Report
  • 91 Pages
  • Global
From

About the Gene Synthesis Market

Gene Synthesis is a technology used in genomics to create custom DNA sequences. It involves synthesizing a gene from its component nucleotides, which are then assembled into a single strand of DNA. The technology is used in a variety of applications, including gene therapy, drug discovery, and agricultural biotechnology. It is also used to create custom DNA libraries for research and development. Gene Synthesis is a rapidly growing market, driven by advances in sequencing technology and the increasing demand for custom DNA sequences. The technology is used in a variety of industries, including pharmaceuticals, biotechnology, and agriculture. It is also used in academic research and in the development of new diagnostic tests. Companies in the Gene Synthesis market include GenScript, DNA2.0, Twist Bioscience, Eurofins Genomics, and Genewiz. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.